NCT02872038View on ClinicalTrials.gov

Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis

PHASE4CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Peritoneal Dialysis Associated Peritonitis
Interventions
DRUG

Cefepime

Cefepime intraperitoneal continuous dosing

DRUG

Cefazolin plus Ceftazidime

Trial Locations (1)

10500

Chulalongkorn University, Bangkok

All Listed Sponsors
collaborator

The Kidney Foundation of Thailand

UNKNOWN

collaborator

Siam Pharmaceutical Co Ltd

UNKNOWN

lead

Chulalongkorn University

OTHER

NCT02872038 - Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis | Biotech Hunter | Biotech Hunter